Real-world data show Ocrevus reduced relapse rates and maintained disability stability in relapsing MS over four years.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...

A Norman cyclist who has lived with multiple sclerosis for nearly two decades is riding coast-to-coast to raise awareness and ...

People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...

Multiple sclerosis is an autoimmune condition where, for reasons scientists are still trying to understand, your body’s immune system suddenly attacks the coating covering the nerves in your brain and ...

Multiple sclerosis (MS) is a chronic disease that affects your brain and spinal cord. When you have it, your immune system -- your body's defense against germs -- attacks the insulation, or myelin, ...

Multiple sclerosis is a central nervous system autoimmune condition that damages myelin sheath that protects the nervous system, affects brain and spinal cord and leads to aggravated conditions like ...

Severity of multiple sclerosis (MS) was linked with geographic latitude, an observational study showed. Among 46,000 MS patients living in temperate zones, more severe disease was seen in those who ...

Bladder problems caused by a disease such as multiple sclerosis (MS) is called neurogenic bladder. MS can disrupt communication between your brain and the bladder, making bladder problems quite common ...